Every year, millions of lives are suddenly, swiftly transformed by a stroke, which occurs when a blood vessel traveling ...

Scientists at EPFL have developed an innovative, non-invasive brain stimulation therapy to significantly improve visual ...

Every 40 seconds, someone in the United States has a stroke. For survivors of the most common type of stroke, called an ...

Acute ischemic stroke remains one of medicine’s most time-sensitive emergencies. When blood flow to the brain becomes blocked, approximately 1.9 million neurons die each minute without intervention.

Revalesio, a clinical-stage biopharmaceutical company developing treatments for acute and chronic neurological disorders, announced today that findings from a post hoc analysis of its Phase 2 RESCUE ...

Every 40 seconds, someone in the United States has a stroke. For survivors of the most common type of stroke, called an ischemic stroke, only about 5 percent fully recover. Most others suffer from ...

A rapid blood test could speed treatment for people who have suffered a stroke related to brain bleeding, a new study says. Stroke victims with brain bleeds have nearly seven times higher blood levels ...

Intravenous thrombolysis is a standard treatment of acute ischemic stroke. The efficacy and safety of combining intravenous thrombolysis with argatroban (an anticoagulant agent) or eptifibatide (an ...

New research provides further evidence that thrombolysis benefits select patients with acute ischemic stroke up to 24 hours after symptom onset. In the HOPE trial, administration of intravenous (IV) ...

In a randomized trial, adding an antiplatelet to anticoagulant therapy in patients with ischemic stroke, nonvalvular atrial fibrillation, and atherosclerosis provided no significant benefit. There was ...